Neparvis
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neparvis, covering 2026-01-13 to 2026-01-13. Get the full timeline:
Most recent: EMA Authorised: Neparvis (sacubitril;valsartan) — Novartis Europharm Limited